SOURCE: Kika Medical

December 11, 2008 14:55 ET

KIKA Medical Celebrates 3rd Year of Preferred Provider Status of Next-Generation EDC for Clinical Asset Management to Global CRO Cardialysis

Independent CRO Focusing on Cardiovascular Indication for Pharmaceutical and Device Markets Cites KIKA Expertise, Speed and Flexibility

BOSTON, MA--(Marketwire - December 11, 2008) - KIKA Medical, the leading provider of advanced EDC (electronic data capture) for clinical trials, marked the third year of a preferred provider partnership with independent CRO Cardialysis. The two companies have collaborated on several successful trials consisting of thousands of patients.

Cardialysis ( is an academic CRO and premier provider of imaging core laboratory techniques, clinical event adjudication services and a set of CRO services for studies in cardiac device and other cardiovascular indications.

Michael J. Koenders, Manager of Business Development at Cardialysis, said, "We named KIKA our preferred EDC provider after a rigorous industry evaluation. KIKA's business model fits extremely well into our commitment to provide fast, adaptable, cost-effective solutions."

KIKA and Cardialysis jointly develop a CRF, define users, roles and other requirements, conduct the validation process, and initiate the trial. Coordination between the companies spans from study operation coordinators to senior executives. This ensures smooth trials that meet sponsor needs at every stage.

Mr. Koenders explained that KIKA's flexibility and ability to create reports that include imaging is extremely important. "KIKA enables us to respond quickly to sponsor requests for new types of imaging and data reports. We would not find that speed, flexibility and capability from any other vendor."

Linda Beneze, CEO of KIKA, said, "We're privileged to have provided our Clinical Asset Management expertise to Cardialysis and look forward to a continued successful partnership to advance EDC adoption in clinical trials."

About KIKA Medical

KIKA helps the world's most innovative medical device and biopharmaceutical companies bring much-needed medical solutions to the market faster. KIKA's Clinical Asset Management platform is an exclusive three-part approach to electronic clinical trial solutions: Veracity™ breakthrough Web-based technology, unparalleled Professional Services, and established T infrastructure. The result is flexibility and customization, end-user empowerment, and responsiveness and support. Visit or call 1-617-619-9990 in the U.S.; +33 (0)1 53 17 95 70 in Europe; or email

KIKA, KIKA Medical and Veracity are among trademarks of KIKA Medical, Inc.

Contact Information

  • Media contacts:

    For KIKA Medical:
    Brenda Nashawaty
    Email Contact

    For Cardialysis:
    Michael Koenders
    Email Contact